Study areas
The study was carried out in rural areas in four districts of the republic of Congo, including Mpouya (in plateaux Department), Mindouli (Department of Pool), Mossaka and Loukolela both located in the Department of Cuvette. These districts are predominated by a tropical savanna climate. Mpouya is a region located at 2°36′57″South, 16°12′43″East with an altitude of 350 m. It is located near the Congo River and comprises 9000 inhabitants mainly involved in agriculture and fishing activities. Mindouli is geo-localized at 4° 16′ 24″ South, 14° 23′ 2″ East. It accounts for 53,584 inhabitants and agriculture is the main economic activity of the region. The district of Mossaka, located at 1° 13′ 53″ South, 16° 46′ 58″ East, accounts for 25,636 inhabitants. It is bounded to the east by the Democratic Republic of Congo and fishing is the main economic activity the locality. The Loukoléla district is geo-localized at 1° 3′ 58″ South, 17° 10′ 6″ East, and has 21,442 inhabitants. It is located on the banks of the Congo River, at about 50 km upstream from the confluence between the Congo and the Sangha. One of the main economic activities in this district is fishing and smoking of fish which is transported to the main consumption centres of the country.
Study design
A cross-sectional study was conducted during a mass diagnostic campaign from June 2020 to January 2021. The population of interest included the participants of all age who lived in the study areas for at least 3 months. During the mass diagnostic in each district, we conducted a simple randomized sampling.
According to the sample size calculator Raosoft 2004, a sample size of 3709 participants was estimated (with a target of having at least 1/4 participants per district, which correspond to 928 participants/district), assuming that the total size of population of the study areas was 109,662, a confidence level was fixed at 95%, an error margin of 0.1% and a prevalence of HAT in Republic of Congo of 0.1% (reference). The below Formula was used to determine the sample size:
$$\textrm{n}=\textrm{N}\times \frac{\frac{{\textrm{Z}}^2\times \textrm{p}\times \left(1-\textrm{p}\right)}{{\textrm{e}}^2}}{\textrm{N}-1+\frac{{\textrm{Z}}^2\times \textrm{p}\times \left(1-\textrm{p}\right)}{{\textrm{e}}^2}}$$
Where n is the sample size; e is the marginal error, N is the population size of the locality; p is the prevalence of HAT. and z is the confidence level.
After obtaining the ethical clearance and the administrative authorizations, the participants were randomly enrolled in the study sites for blood sample collection. A consent form was provided by the participants or the parent of minor (< 18 years) participants. The sociodemographic and clinical parameters of the participants were recorded in a well-structured collection sheet (age, gender, school level, occupation etc). EDTA-blood (3 ml) and cerebrospinal fluid (CSF) were collected by a nurse, and transported to the Reference health Centre of each district for further processing. HAT screening was done according to the Algorithm of the national Program of HAT control in Republic of Congo. The first test was done using the card agglutination test for trypanosomiasis (CATT) in whole blood and plasma samples of each participant. The Capillary Tube Centrifugation (CTC) technique was used as additional test for detecting trypanosoma parasites in participants with a positive CATT. The HAT positive cases were treated either with stage 1 or stage 2 protocol based on the results of the cerebrospinal fluid (CSF) examination, according to National Control Program for HAT of Republic of Congo.
Diagnosis of human African Trypanosomiasis
The diagnostic of HAT was based on active screening of the infection. Results of antibody and parasite detection were necessary to make the final decision of participant clinical status.
Titre antibody screening
CATT/T.b. gambiense was used for the detection of the T.b. gambiense specific antibody in sample as described by the manufacturers [13]. Briefly, the undiluted blood samples of each participant were firstly tested for HAT antibodies. The participants with a positive result were confirmed following antibody detection titration-method in plasma samples using the CATT. The titre (highest dilution giving agglutination) was determined. Participants with titres < 1∶8 were considered CATT negative, while titres ≥1∶8 were considered CATT positive.
Parasite detection and classification of HAT stages
The Capillary Tube Centrifugation (CTC) and Lymph nodes (LN) examination were used as additional test for detecting trypanosome parasites in participants with a positive CATT. All participants positive with CATT but negative with CTC were considered as healthy carriers [8, 14]. The presence of trypanosome and the number of white blood cells in the CSF were assessed to classify the disease progress of positive participants. The screening of the parasite was done after centrifugation of CSF immediately after lumbar puncture [15]. The disease progress was classified as first stage when no trypanosomes were detected in the CSF and the WBC count was ≤5 WBC/μl. The second stage of the disease was defined by the presence of trypanosomes in the CSF with > 5 WBC/μl.
Data analysis
Data management and tabulation were carried out using EpiInfo7 version 7.2.2.6 and Microsoft Excel 2010. All statistical analyses were done using R version 3.6.3 (2020-02-29) and RStudio Version 1.2.5033 software. The normality of data distribution was checked using the Shapiro–Wilk test [16]. Qualitative data were expressed as percentages, and quantitative data by medians (with range) or mean (standard deviation). Pearson’s Chi-square test (or Fisher’s exact tests when appropriate) was used to compare percentages between groups. The strength of association between each of the potential risk factors and the occurrence of HAT was calculated using univariate logistic regression using the complete cases. The odds ratios (OR) are given with a 95% confidence interval (CI). The statistical significance threshold for the tests was set at 5%.
Ethical consideration
This study received an ethical approval from the Institutional Ethics Committee of Fondation Congolaise pour la Recherche Medical (Ethical Clearance N° 023/CIE/FCRM/2019) and the administrative authorisations from each mayor of the areas. All experiments were performed in accordance with relevant guidelines and regulations. Prior to enrolment, participants were informed in writing and orally about the study and its benefits. A written informed consent form was obtained from the adult participants for participating in the study. For the minor (< 18 years) a written informed consent form was obtained from their parent/guardian. In addition, a written assent form was obtained from children aged between 15 to 17 years hold.